H-VAL-LYS-PHE-GLY-VAL-GLY-PHE-LYS-OH
H-VAL-LYS-PHE-GLY-VAL-GLY-PHE-LYS-OH
H-VAL-LYS-PHE-GLY-VAL-GLY-PHE-LYS-OH 性质
| 储存条件 | Desiccate at -20°C |
|---|---|
| 溶解度 | water, double-distilled: soluble |
| 形态 | 粉末 |
| 颜色 | 白色至米白色 |
| 水溶解性 | Soluble to 1 mg/ml in water |
H-VAL-LYS-PHE-GLY-VAL-GLY-PHE-LYS-OH 用途与合成方法
|
Ca 2+
|
CALP3 (50, 100, 150, 200 μM) inhibits glutamate caused a large sustained increase in [Ca
2+
]
i
in a dose-dependent manner (IC
50
=37.25 μM) in Fura-2-loaded neuronal cultures.
CALP3 (50, 100, 150, 200 μM) inhibits glutamate-induced cytotoxicity in a dose-dependent manner (IC
50
=50.97 μM) in cultured rat neocortical neurons. CALP3 causes dose-dependent inhibition of apoptosis (IC
50
=33.41 μM).
CALP3 (100 μM) inhibits apoptosis induced by HIV gp120 and SAg in Human T cells.
CALP3 (100 μM; 15 min pretreatment) reduces gossypol-induced necrosis and increases the fraction of live cells.
Cyclic-CALP3 is synthesized starting from Fmoc-Asp(PEG-PS)-OAl. Cyclic CALP3 is unable to inhibit Ca21 influx, and this peptide served as a negative control. Cyclic CALP3 does not inhibit the effect of glutamate.
H-VAL-LYS-PHE-GLY-VAL-GLY-PHE-LYS-OH 价格(试剂级)
| 更新日期 | 产品编号 | 产品名称 | CAS号 | 包装 | 价格 |
|---|---|---|---|---|---|
| 2026-09-15 | HY-P1075 | H-VAL-LYS-PHE-GLY-VAL-GLY-PHE-LYS-OH | 261969-05-5 | 1mg | 550 |
| 2026-09-15 | HY-P1075 | H-VAL-LYS-PHE-GLY-VAL-GLY-PHE-LYS-OH | 261969-05-5 | 5mg | 950 |
